Plasma protein corona modulates the vascular wall interaction of drug carriers in a material and donor specific manner

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Sobczynski, Daniel J ^a   Charoenphol, Phapanin ^a   Heslinga, Michael J ^a,b   Onyskiw, Peter J ^a   Namdee, Katawut ^a   Thompson, Alex J ^a   Eniola Adefeso, Omolola ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; CORONA PROTEIN; DRUG CARRIER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN; NANOSPHERE; PLASMA PROTEIN; POLYGLACTIN; POLYSTYRENE; SILICON DIOXIDE; UNCLASSIFIED DRUG; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; PROTEIN BINDING; PROTEIN CORONA;

ADSORPTION KINETICS; ARTICLE; BINDING KINETICS; BLOOD FLOW; BLOOD VESSEL WALL; CELL ADHESION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR WEIGHT; PARTICLE SIZE; PROTEIN DEPLETION; PROTEIN INTERACTION; SURFACE PROPERTY; UMBILICAL VEIN ENDOTHELIAL CELL; ADSORPTION; CHEMISTRY; ENDOTHELIUM CELL; FOCAL ADHESION; METABOLISM;

ADSORPTION; BLOOD PROTEINS; DRUG CARRIERS; ENDOTHELIAL CELLS; FOCAL ADHESIONS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LACTIC ACID; PARTICLE SIZE; POLYGLYCOLIC ACID; PROTEIN BINDING; PROTEIN CORONA;

EID: 84907202338     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107408     Document Type: Article

References (50)

1. Allen TM, Cullis PR (2004) Drug delivery systems: entering the mainstream. Science 303: 1818-1822
2. Hajitou A, Pasqualini R, Arap W (2006) Vascular targeting: recent advances and therapeutic perspectives. Trends Cardiovasc Med 16: 80-88
3. Charoenphol P, Onyskiw PJ, Carrasco-Teja M, Eniola-Adefeso O (2012) Particle-cell dynamics in human blood flow: implications for vascular-targeted drug delivery. J Biomech 45: 2822-2828
4. Namdee K, Thompson AJ, Charoenphol P, Eniola-Adefeso O (2013) Margination propensity of vascular-targeted spheres from blood flow in a microfluidic model of human microvessels. Langmuir 29: 2530-2535
5. Thompson AJ, Mastria EM, Eniola-Adefeso O (2013) The margination propensity of ellipsoidal micro/nanoparticles to the endothelium in human blood flow. Biomaterials 34: 5863-5871
6. Yan Y, Gause KT, Kamphuis MM, Ang CS, O'Brien-Simpson NM, et al. (2013) Differential roles of the protein corona in the cellular uptake of nanoporous polymer particles by monocyte and macrophage cell lines. ACS Nano 7: 10960-10970
7. Mortimer GM, Butcher NJ, Musumeci AW, Deng ZJ, Martin DJ, et al. (2014) Cryptic epitopes of albumin determine mononuclear phagocyte system clearance of nanomaterials. ACS Nano 8: 3357-3366
8. Pozzi D, Colapicchioni V, Caracciolo G, Piovesana S, Capriotti AL, et al. (2014) Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells. Nanoscale 6: 2782-2792
9. Sempf K, Arrey T, Gelperina S, Schorge T, Meyer B, et al. (2013) Adsorption of plasma proteins on uncoated PLGA nanoparticles. Eur J Pharm Biopharm 85: 53-60
10. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, et al. (2008) Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A 105: 14265-14270
11. Mirshafiee V, Mahmoudi M, Lou K, Cheng J, Kraft ML (2013) Protein corona significantly reduces active targeting yield. Chem Commun (Camb) 49: 2557-2559
12. Salvati A, Pitek AS, Monopoli MP, Prapainop K, Bombelli FB, et al. (2013) Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol 8: 137-143
13. Fleischer CC, Kumar U, Payne CK (2013) Cellular Binding of Anionic Nanoparticles is Inhibited by Serum Proteins Independent of Nanoparticle Composition. Biomater Sci 1: 975-982
14. Caracciolo G, Cardarelli F, Pozzi D, Salomone F, Maccari G, et al. (2013) Selective targeting capability acquired with a protein corona adsorbed on the surface of 1,2-dioleoyl-3-trimethylammonium propane/DNA nanoparticles. ACS Appl Mater Interfaces 5: 13171-13179
15. Deng ZJ, Mortimer G, Schiller T, Musumeci A, Martin D, et al. (2009) Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology 20: 455101
16. Kuo SC, Hammer DA, Lauffenburger DA (1997) Simulation of detachment of specifically bound particles from surfaces by shear flow. Biophys J 73: 517-531
17. Lee TR, Choi M, Kopacz AM, Yun SH, Liu WK, et al. (2013) On the near-wall accumulation of injectable particles in the microcirculation: smaller is not better. Sci Rep 3: 2079
18. Lee SY, Ferrari M, Decuzzi P (2009) Design of bio-mimetic particles with enhanced vascular interaction. J Biomech 42: 1885-1890
19. Lee SY, Ferrari M, Decuzzi P (2009) Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows. Nanotechnology 20: 495101
20. Onyskiw PJ, Eniola-Adefeso O (2013) Effect of PEGylation on ligand-based targeting of drug carriers to the vascular wall in blood flow. Langmuir 29: 11127-11134
21. Zhang W, Stanimirovic D (2002) Current and future therapeutic strategies to target inflammation in stroke. Current drug targets Inflammation and allergy 1: 151-166
22. Schwendeman SP, Shah RB, Bailey BA, Schwendeman AS (2014) Injectable controlled release depots for large molecules. J Control Release.
23. Sah H, Thoma LA, Desu HR, Sah E, Wood GC (2013) Concepts and practices used to develop functional PLGA-based nanoparticulate systems. Int J Nanomedicine 8: 747-765
24. Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, et al. (2012) PLGAbased nanoparticles: an overview of biomedical applications. J Control Release 161: 505-522
25. Xu H, Kona S, Su LC, Tsai YT, Dong JF, et al. (2013) Multi-ligand poly(Llactic- co-glycolic acid) nanoparticles inhibit activation of endothelial cells. J Cardiovasc Transl Res 6: 570-578
26. Kona S, Dong JF, Liu Y, Tan J, Nguyen KT (2012) Biodegradable nanoparticles mimicking platelet binding as a targeted and controlled drug delivery system. Int J Pharm 423: 516-524
27. Fillafer C, Ratzinger G, Neumann J, Guttenberg Z, Dissauer S, et al. (2009) An acoustically-driven biochip - impact of flow on the cell-association of targeted drug carriers. Lab Chip 9: 2782-2788
28. Muro S, Dziubla T, Qiu W, Leferovich J, Cui X, et al. (2006) Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1. J Pharmacol Exp Ther 317: 1161-1169
29. Omolola Eniola A, Hammer DA (2005) In vitro characterization of leukocyte mimetic for targeting therapeutics to the endothelium using two receptors. Biomaterials 26: 7136-7144
30. Eniola AO, Hammer DA (2005) Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes II: effect of degradation on targeting activity. Biomaterials 26: 661-670
31. Ali M, Hicks AE, Hellewell PG, Thoma G, Norman KE (2004) Polymers bearing sLex-mimetics are superior inhibitors of E-selectin-dependent leukocyte rolling in vivo. FASEB J 18: 152-154
32. Boutry S, Laurent S, Elst LV, Muller RN (2006) Specific E-selectin targeting with a superparamagnetic MRI contrast agent. Contrast media & molecular imaging 1: 15-22
33. Van Langendonckt A, Donnez J, Defrere S, Dunselman GA, Groothuis PG (2008) Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises. Molecular human reproduction 14: 259-268
34. Heslinga MJ, Mastria EM, Eniola-Adefeso O (2009) Fabrication of biodegradable spheroidal microparticles for drug delivery applications. J Control Release 138: 235-242
35. Watts PJ, Davies MC, Melia CD (1990) Microencapsulation using emulsification/ solvent evaporation: an overview of techniques and applications. Crit Rev Ther Drug Carrier Syst 7: 235-259
36. Charoenphol P, Huang RB, Eniola-Adefeso O (2010) Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers. Biomaterials 31: 1392-1402
37. Huang RB, Eniola-Adefeso O (2012) Shear stress modulation of IL-1betainduced E-selectin expression in human endothelial cells. PLoS One 7: e31874
38. Burns AR, Walker DC, Brown ES, Thurmon LT, Bowden RA, et al. (1997) Neutrophil transendothelial migration is independent of tight junctions and occurs preferentially at tricellular corners. J Immunol 159: 2893-2903
39. Unger RE, Krump-Konvalinkova V, Peters K, Kirkpatrick CJ (2002) In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R. Microvasc Res 64: 384-397
40. Huang RB, Gonzalez AL, Eniola-Adefeso O (2013) Laminar shear stress elicit distinct endothelial cell E-selectin expression pattern via TNFalpha and IL-1beta activation. Biotechnol Bioeng 110: 999-1003
41. Safi M, Courtois J, Seigneuret M, Conjeaud H, Berret JF (2011) The effects of aggregation and protein corona on the cellular internalization of iron oxide nanoparticles. Biomaterials 32: 9353-9363
42. Galimard A, Safi M, Ould-Moussa N, Montero D, Conjeaud H, et al. (2012) Thirty-femtogram detection of iron in mammalian cells. Small 8: 2036-2044
43. Kittler S, Greulich C, Gebauer JS, Diendorf J, Treuel L, et al. (2010) The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles. J Mater Chem 20: 512-518
44. Charoenphol P, Mocherla S, Bouis D, Namdee K, Pinsky DJ, et al. (2011) Targeting therapeutics to the vascular wall in atherosclerosis-carrier size matters. Atherosclerosis 217: 364-370
45. Tenzer S, Docter D, Rosfa S, Wlodarski A, Kuharev J, et al. (2011) Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano 5: 7155-7167
46. Yovita H, Djumhana A, Abdurachman SA, Saketi JR (2004) Correlation between anthropometrics measurements, prealbumin level and transferin serum with Child-Pugh classification in evaluating nutritional status of liver cirrhosis patient. Acta Med Indones 36: 197-201
47. Walkey CD, Chan WC (2012) Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev 41: 2780-2799
48. Decuzzi P, Lee S, Bhushan B, Ferrari M (2005) A theoretical model for the margination of particles within blood vessels. Ann Biomed Eng 33: 179-190
49. Gref R, Luck M, Quellec P, Marchand M, Dellacherie E, et al. (2000) 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces 18: 301-313
50. Medina SH, Tiruchinapally G, Chevliakov MV, Durmaz YY, Stender RN, et al. (2013) Targeting hepatic cancer cells with pegylated dendrimers displaying Nacetylgalactosamine and SP94 peptide ligands. Adv Healthc Mater 2: 1337-1350